Hanna N, Ovadia H, Nelken D
Immunology. 1978 Jun;34(6):1007-15.
Normal immunosuppressive protein isolated from human plasma was found to inhibit the generation of primary cytotoxic effector lymphocytes against allogeneic tumour cells in vitro. Total inhibition was observed when NIP was present during the early stages of the sensitization process. In contrast, the generation of secondary cytotoxic lymphocytes in vitro was only slightly inhibited even though large amounts of NIP were used. The inhibition of target cell lysis by sensitized lymphocytes required long preincubation of a relatively small number of effector cells with large amounts of NIP and was most significant when tested at low effector: target cell ratios. Under the same conditions NIP showed no inhibitory effect on the cytotoxic activity of immune macrophages. The present in vitro experiments suggest that NIP exerts its effect through inhibition of DNA synthesis and cellular proliferation and to a limited extent only, by inducing specific suppressor cells.
从人血浆中分离出的正常免疫抑制蛋白在体外可抑制针对同种异体肿瘤细胞的原发性细胞毒性效应淋巴细胞的生成。当在致敏过程的早期阶段存在NIP时,观察到完全抑制。相比之下,即使使用大量NIP,体外继发性细胞毒性淋巴细胞的生成也仅受到轻微抑制。致敏淋巴细胞对靶细胞裂解的抑制需要将相对少量的效应细胞与大量NIP长时间预孵育,并且在低效应细胞:靶细胞比例下进行测试时最为显著。在相同条件下,NIP对免疫巨噬细胞的细胞毒性活性没有抑制作用。目前的体外实验表明,NIP通过抑制DNA合成和细胞增殖发挥作用,并且仅在有限程度上通过诱导特异性抑制细胞发挥作用。